Hematology
What they do most for Medicare patients
| Service, sort | Times billed, sort |
|---|---|
| Special stained specimen slides to identify organisms including interpretation and report | 1,018 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 1,031 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 1,063 |
| New patient office or other outpatient visit, 30-44 minutes | 1,066 |
| Infusion into a vein for hydration, 31-60 minutes | 1,101 |
| Ct guidance for insertion of radiation therapy fields | 1,125 |
| Infusion into a vein for hydration, each additional hour | 1,129 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 1,149 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 1,168 |
| Antibody identification test, platelet associated immunoglobulin assay | 1,237 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 1,245 |
| Vitamin d-3 level | 1,264 |
| Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | 1,281 |
| Blood test, thyroid stimulating hormone (tsh) | 1,349 |
| Measurement of immunoglobulin light chains | 1,372 |
| Evaluation of fine needle aspirate with interpretation and report | 1,382 |
| Telephone medical discussion with physician, 11-20 minutes | 1,388 |
| Hospital discharge day management, 30 minutes or less | 1,403 |
| Detection test by nucleic acid for human papillomavirus (hpv), high-risk types | 1,425 |
| Established patient office or other outpatient visit, 10-19 minutes | 1,429 |
| Carcinoembryonic antigen (cea) protein level | 1,484 |
| Microscopic genetic analysis of tissue, manual, each additional procedure | 1,629 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 1,677 |
| Telephone medical discussion with physician, 21-30 minutes | 1,757 |
| Genetic sequencing localization, each additional procedure | 1,759 |
| Pap test, automated thin layer preparation; automated system | 1,769 |
| Pathology clinical consultation for clinical problem, 5-20 minutes | 1,775 |
| Testosterone (hormone) level, total | 1,830 |
| Administration of chemotherapy into vein, each additional hour | 1,959 |
| Cyanocobalamin (vitamin b-12) level | 2,095 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 2,344 |
| Pathology examination of tissue using a microscope, moderately low complexity | 2,362 |
| Administration of additional new drug or substance into vein, 1 hour or less | 2,368 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,380 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 2,422 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 2,505 |
| Psa (prostate specific antigen) measurement, total | 2,585 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 2,614 |
| Cell examination of specimen, selective cellular enhancement technique | 2,784 |
| Hospital discharge day management, more than 30 minutes | 2,823 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 2,895 |
| Genetic sequencing localization, initial procedure | 2,955 |
| Gammaglobulin (immune system protein) measurement | 3,338 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 3,361 |
| Coagulation function screening test with interpretation and report | 3,389 |
| Interpretation and report of genetic testing | 3,462 |
| Flow cytometry technique for dna or cell analysis, first marker | 3,779 |
| Flow cytometry technique for dna or cell analysis, 2 to 8 markers | 4,058 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 4,228 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 4,464 |
| Pathology examination of tissue using a microscope, moderately high complexity | 5,117 |
| Protein measurement, body fluid | 5,461 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 5,667 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 5,696 |
| Iron binding capacity | 5,811 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 5,846 |
| Iron level | 5,924 |
| Phosphate level | 5,930 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 6,192 |
| New patient office or other outpatient visit, 45-59 minutes | 6,294 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 6,347 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 6,347 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 6,353 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 6,354 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 6,367 |
| Ferritin (blood protein) level | 6,495 |
| Blood smear interpretation by physician with written report | 6,615 |
| Uric acid level, blood | 6,659 |
| Magnesium level | 7,854 |
| Molecular pathology procedure; physician interpretation and report | 8,710 |
| Cell examination of urine, manual | 8,829 |
| Injection of additional new drug or substance into vein | 8,935 |
| Administration of chemotherapy into vein, 1 hour or less | 8,937 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 9,928 |
| Injection of drug or substance under skin or into muscle | 11,195 |
| Microscopic genetic analysis of tumor, manual | 11,583 |
| New patient office or other outpatient visit, 60-74 minutes | 14,204 |
| Bone marrow, smear interpretation | 15,300 |
| Cell examination of specimen, concentration technique | 15,569 |
| Lactate dehydrogenase (enzyme) level | 16,917 |
| Preparation of tissue for examination by removing any calcium present | 17,124 |
| Immunologic analysis technique on serum (immunofixation) | 17,263 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 18,577 |
| Special stained specimen slides to examine tissue, initial procedure | 23,337 |
| Protein measurement, serum | 23,591 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 24,294 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 27,078 |
| Special stained specimen slides to examine tissue including interpretation and report | 30,840 |
| Detection test for candida species (yeast), amplified probe technique | 32,718 |
| Established patient office or other outpatient visit, 20-29 minutes | 35,364 |
| Blood test, comprehensive group of blood chemicals | 38,174 |
| Insertion of needle into vein for collection of blood sample | 39,366 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 59,179 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 63,638 |
| Pathology examination of tissue using a microscope, intermediate complexity | 65,392 |
| Special stained specimen slides to examine tissue, each additional procedure | 80,329 |
| Detection test by nucleic acid for organism, amplified probe technique | 81,879 |
| Established patient office or other outpatient visit, 40-54 minutes | 81,888 |
| Flow cytometry technique for dna or cell analysis, each additional marker | 85,667 |
| Established patient office or other outpatient visit, 30-39 minutes | 131,318 |
Sources: Medicare Care Compare (hospitals and schools; Medicare-enrolled clinicians), CMS Medicare Physician & Other Practitioners 2023 (services), Medicare Part D Prescribers 2024 (drugs).